chlorambucil,venetoclax,obinutuzumab
abbvie,roche
['lymsm', 'cll14', 'lymphoma', 'cll']
congress|#17icml , presents the 6-yr results of the cll14 study. compared to clb-obi, fixed duration ven-obi showed a long-term pfs benefit across all subgroups of pts with previously untreated cll, with no new safety signals reported #lymsm #lymphoma 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm